Johnson Net Income Per Share vs Days Sales Outstanding Analysis

JNJ Stock

USD 147.03 0.74 0.50%

Johnson Johnson financial indicator trend analysis is infinitely more than just investigating Johnson Johnson recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Johnson Johnson is a good investment. Please check the relationship between Johnson Johnson Net Income Per Share and its Days Sales Outstanding accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

Net Income Per Share vs Days Sales Outstanding

Net Income Per Share vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Johnson Johnson Net Income Per Share account and Days Sales Outstanding. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Johnson Johnson's Net Income Per Share and Days Sales Outstanding is -0.58. Overlapping area represents the amount of variation of Net Income Per Share that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Johnson Johnson, assuming nothing else is changed. The correlation between historical values of Johnson Johnson's Net Income Per Share and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income Per Share of Johnson Johnson are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Net Income Per Share i.e., Johnson Johnson's Net Income Per Share and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.58

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Income Per Share

Days Sales Outstanding

Most indicators from Johnson Johnson's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Johnson Johnson current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.At this time, Johnson Johnson's Issuance Of Capital Stock is relatively stable compared to the past year. Sales General And Administrative To Revenue is expected to hike to 0.28 this year, although Enterprise Value Over EBITDA will most likely fall to 10.11.

	2022	2023	2024	2025 (projected)
Gross Profit	55.4B	58.4B	67.2B	34.3B
Total Revenue	80.0B	85.2B	97.9B	49.3B

Gross Profit Total Revenue

Johnson Johnson fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Property Plant And Equipment Gross
Total Assets		0.94	0.83	0.93	0.88	0.79	0.62	0.92	0.65	0.97	0.55	0.32	0.98	-0.71	0.9	0.96	0.34	-0.78	0.96	0.59	0.3	0.82	0.97	0.83	0.03	0.73
Short Long Term Debt Total	0.94		0.82	0.89	0.7	0.7	0.79	0.81	0.51	0.96	0.56	0.19	0.88	-0.65	0.94	0.85	0.19	-0.74	0.97	0.46	0.31	0.86	0.89	0.69	-0.05	0.67
Other Current Liab	0.83	0.82		0.95	0.56	0.54	0.63	0.84	0.44	0.9	0.73	-0.11	0.82	-0.85	0.78	0.86	0.14	-0.88	0.9	0.2	0.09	0.69	0.9	0.46	-0.29	0.87
Total Current Liabilities	0.93	0.89	0.95		0.75	0.65	0.65	0.92	0.54	0.94	0.77	0.11	0.9	-0.83	0.8	0.94	0.32	-0.87	0.94	0.4	0.33	0.69	0.96	0.64	-0.11	0.89
Total Stockholder Equity	0.88	0.7	0.56	0.75		0.77	0.31	0.83	0.71	0.75	0.46	0.6	0.86	-0.51	0.63	0.87	0.58	-0.58	0.72	0.78	0.45	0.56	0.82	0.91	0.3	0.59
Property Plant And Equipment Net	0.79	0.7	0.54	0.65	0.77		0.41	0.67	0.56	0.73	0.29	0.56	0.77	-0.35	0.7	0.72	0.46	-0.57	0.72	0.84	0.3	0.68	0.72	0.9	0.14	0.42
Net Debt	0.62	0.79	0.63	0.65	0.31	0.41		0.41	-0.12	0.72	0.49	-0.03	0.49	-0.31	0.73	0.48	0.01	-0.4	0.73	0.19	0.28	0.74	0.61	0.27	0.05	0.44
Retained Earnings	0.92	0.81	0.84	0.92	0.83	0.67	0.41		0.74	0.88	0.59	0.24	0.93	-0.88	0.76	0.99	0.26	-0.91	0.87	0.47	0.19	0.62	0.93	0.73	-0.07	0.84
Cash	0.65	0.51	0.44	0.54	0.71	0.56	-0.12	0.74		0.55	0.22	0.35	0.75	-0.63	0.51	0.71	0.31	-0.63	0.55	0.48	0.11	0.37	0.59	0.74	-0.16	0.47
Non Current Assets Total	0.97	0.96	0.9	0.94	0.75	0.73	0.72	0.88	0.55		0.57	0.1	0.95	-0.74	0.94	0.92	0.23	-0.81	0.99	0.42	0.21	0.89	0.94	0.71	-0.16	0.74
Non Currrent Assets Other	0.55	0.56	0.73	0.77	0.46	0.29	0.49	0.59	0.22	0.57		-0.04	0.46	-0.59	0.33	0.59	0.44	-0.6	0.55	0.18	0.57	0.2	0.61	0.24	-0.09	0.82
Cash And Short Term Investments	0.32	0.19	-0.11	0.11	0.6	0.56	-0.03	0.24	0.35	0.1	-0.04		0.26	0.14	0.13	0.25	0.36	0.0	0.13	0.9	0.41	0.06	0.26	0.64	0.82	-0.03
Net Receivables	0.98	0.88	0.82	0.9	0.86	0.77	0.49	0.93	0.75	0.95	0.46	0.26		-0.76	0.89	0.97	0.29	-0.82	0.94	0.54	0.17	0.81	0.95	0.84	-0.1	0.72
Common Stock Shares Outstanding	-0.71	-0.65	-0.85	-0.83	-0.51	-0.35	-0.31	-0.88	-0.63	-0.74	-0.59	0.14	-0.76		-0.62	-0.83	0.0	0.89	-0.75	-0.06	0.03	-0.46	-0.78	-0.39	0.38	-0.85
Non Current Liabilities Total	0.9	0.94	0.78	0.8	0.63	0.7	0.73	0.76	0.51	0.94	0.33	0.13	0.89	-0.62		0.81	0.03	-0.7	0.96	0.4	0.04	0.96	0.86	0.69	-0.14	0.54
Inventory	0.96	0.85	0.86	0.94	0.87	0.72	0.48	0.99	0.71	0.92	0.59	0.25	0.97	-0.83	0.81		0.31	-0.88	0.91	0.51	0.2	0.71	0.96	0.77	-0.06	0.83
Other Current Assets	0.34	0.19	0.14	0.32	0.58	0.46	0.01	0.26	0.31	0.23	0.44	0.36	0.29	0.0	0.03	0.31		-0.08	0.17	0.55	0.68	0.02	0.29	0.51	0.16	0.28
Other Stockholder Equity	-0.78	-0.74	-0.88	-0.87	-0.58	-0.57	-0.4	-0.91	-0.63	-0.81	-0.6	0.0	-0.82	0.89	-0.7	-0.88	-0.08		-0.82	-0.26	-0.03	-0.55	-0.84	-0.51	0.31	-0.86
Total Liab	0.96	0.97	0.9	0.94	0.72	0.72	0.73	0.87	0.55	0.99	0.55	0.13	0.94	-0.75	0.96	0.91	0.17	-0.82		0.42	0.17	0.88	0.95	0.7	-0.13	0.73
Total Current Assets	0.59	0.46	0.2	0.4	0.78	0.84	0.19	0.47	0.48	0.42	0.18	0.9	0.54	-0.06	0.4	0.51	0.55	-0.26	0.42		0.48	0.35	0.52	0.85	0.59	0.22
Short Term Debt	0.3	0.31	0.09	0.33	0.45	0.3	0.28	0.19	0.11	0.21	0.57	0.41	0.17	0.03	0.04	0.2	0.68	-0.03	0.17	0.48		-0.02	0.2	0.37	0.35	0.26
Intangible Assets	0.82	0.86	0.69	0.69	0.56	0.68	0.74	0.62	0.37	0.89	0.2	0.06	0.81	-0.46	0.96	0.71	0.02	-0.55	0.88	0.35	-0.02		0.76	0.64	-0.15	0.39
Accounts Payable	0.97	0.89	0.9	0.96	0.82	0.72	0.61	0.93	0.59	0.94	0.61	0.26	0.95	-0.78	0.86	0.96	0.29	-0.84	0.95	0.52	0.2	0.76		0.73	0.01	0.83
Common Stock Total Equity	0.83	0.69	0.46	0.64	0.91	0.9	0.27	0.73	0.74	0.71	0.24	0.64	0.84	-0.39	0.69	0.77	0.51	-0.51	0.7	0.85	0.37	0.64	0.73		0.22	0.39
Short Term Investments	0.03	-0.05	-0.29	-0.11	0.3	0.14	0.05	-0.07	-0.16	-0.16	-0.09	0.82	-0.1	0.38	-0.14	-0.06	0.16	0.31	-0.13	0.59	0.35	-0.15	0.01	0.22		-0.19
Property Plant And Equipment Gross	0.73	0.67	0.87	0.89	0.59	0.42	0.44	0.84	0.47	0.74	0.82	-0.03	0.72	-0.85	0.54	0.83	0.28	-0.86	0.73	0.22	0.26	0.39	0.83	0.39	-0.19

Click cells to compare fundamentals

Johnson Johnson Account Relationship Matchups

Johnson Johnson fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	174.9B	182.0B	187.4B	167.6B	192.7B	202.3B
Short Long Term Debt Total	35.3B	33.8B	39.6B	29.3B	33.7B	35.4B
Other Current Liab	29.0B	29.3B	30.9B	30.2B	34.7B	36.5B
Total Current Liabilities	42.5B	45.2B	55.8B	46.3B	53.2B	55.9B
Total Stockholder Equity	63.3B	74.0B	76.8B	68.8B	79.1B	83.0B
Property Plant And Equipment Net	18.8B	19.0B	18.0B	19.9B	22.9B	11.6B
Net Debt	21.3B	19.3B	26.8B	7.5B	8.6B	9.0B
Retained Earnings	113.9B	123.1B	128.3B	153.8B	176.9B	185.8B
Cash	14.0B	14.5B	12.9B	21.9B	25.1B	26.4B
Non Current Assets Total	123.7B	121.0B	132.1B	114.1B	131.2B	137.7B
Non Currrent Assets Other	6.6B	10.2B	30.6B	14.2B	16.3B	17.1B
Cash And Short Term Investments	25.2B	31.6B	22.3B	22.9B	26.4B	14.3B
Net Receivables	13.6B	15.3B	14.0B	14.9B	17.1B	18.0B
Common Stock Shares Outstanding	2.7B	2.7B	2.7B	2.6B	2.3B	2.2B
Liabilities And Stockholders Equity	174.9B	182.0B	187.4B	167.6B	192.7B	202.3B
Non Current Liabilities Total	69.1B	62.8B	54.8B	52.5B	60.4B	63.4B
Inventory	9.3B	10.4B	10.3B	11.2B	12.9B	13.5B
Other Current Assets	3.1B	3.7B	8.7B	4.5B	5.2B	3.5B
Other Stockholder Equity	(38.5B)	(39.1B)	(41.7B)	(75.7B)	(68.1B)	(64.7B)
Total Liab	111.6B	108.0B	110.6B	98.8B	113.6B	119.3B
Total Current Assets	51.2B	61.0B	55.3B	53.5B	61.5B	31.1B
Short Term Debt	2.6B	3.8B	12.8B	3.5B	4.0B	3.0B
Intangible Assets	53.4B	46.4B	38.5B	34.2B	39.3B	41.3B
Accounts Payable	9.5B	11.1B	9.9B	9.6B	11.1B	11.6B
Short Term Investments	11.2B	17.1B	9.4B	1.1B	1.2B	1.2B
Property Plant And Equipment Gross	18.8B	47.7B	49.3B	47.8B	54.9B	57.7B
Accumulated Other Comprehensive Income	(15.2B)	(13.1B)	(13.0B)	(12.5B)	(11.3B)	(10.7B)
Other Liab	35.1B	35.4B	31.8B	26.6B	30.6B	18.8B
Other Assets	11.4B	3.9B	17.2B	17.0B	19.6B	20.6B
Long Term Debt	32.6B	30.0B	26.9B	25.9B	29.8B	15.4B
Good Will	36.4B	35.2B	36.0B	36.6B	42.0B	21.5B
Treasury Stock	(38.5B)	(39.1B)	(41.7B)	(75.7B)	(68.1B)	(64.7B)
Property Plant Equipment	17.7B	18.8B	19.0B	19.8B	22.8B	15.8B
Net Tangible Assets	(21.8B)	(26.5B)	(13.1B)	(16.8B)	(15.1B)	(14.3B)
Retained Earnings Total Equity	110.7B	113.9B	123.1B	128.3B	147.6B	110.0B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:

How To Invest In Johnson

Details

Is Johnson Stock a good investment?

Details

What is Johnson Johnson's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.89)

Dividend Share

4.86

Earnings Share

6.04

Revenue Per Share

36.428

Quarterly Revenue Growth

0.052

The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Johnson Net Income Per Share vs Days Sales Outstanding Analysis

Net Income Per Share vs Days Sales Outstanding

Net Income Per Share vs Days Sales Outstanding Correlation Analysis

Correlation Coefficient

Net Income Per Share

Days Sales Outstanding

Johnson Johnson fundamental ratios Correlations

Johnson Johnson Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Johnson Johnson fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 0.99	Retained Earnings
Total Liab	+ 0.99	Non Current Assets Total
Net Receivables	+ 0.98	Total Assets
Non Current Assets Total	+ 0.97	Total Assets
Accounts Payable	+ 0.97	Total Assets
Total Liab	+ 0.97	Short Long Term Debt Total

Other Stockholder Equity	- 0.91	Retained Earnings
Other Stockholder Equity	- 0.88	Inventory
Common Stock Shares Outstanding	- 0.88	Retained Earnings
Other Stockholder Equity	- 0.88	Other Current Liab
Other Stockholder Equity	- 0.87	Total Current Liabilities
Property Plant And Equipment Gross	- 0.86	Other Stockholder Equity